Lack of Effect of Lovastatin on Restenosis after Coronary Angioplasty

Restenosis after percutaneous transluminal coronary angioplasty (PTCA): A report from the PTCA registry of the national heart, lung, and blood institute

1984 • 1,122 citations

Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia

1990 • 999 citations

Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS)

1992 • 847 citations

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.

1993 • 833 citations

Platelet Function in Hyperlipoproteinemia

1974 • 682 citations

Coronary Angiographic Changes with Lovastatin Therapy: The Monitored Atherosclerosis Regression Study (MARS)

1993 • 637 citations

Does the new angiotensin converting enzyme inhibitor cilazapril prevent restenosis after percutaneous transluminal coronary angioplasty? Results of the MERCATOR study: a multicenter, randomized, double-blind placebo-controlled trial. Multicenter European Research Trial with Cilazapril after Angioplasty to Prevent Transluminal Coronary Obstruction and Restenosis (MERCATOR) Study Group.

1992 • 548 citations

Effects of monotherapy with an HMG-CoA reductase inhibitor on the progression of coronary atherosclerosis as assessed by serial quantitative arteriography. The Canadian Coronary Atherosclerosis Intervention Trial.

1994 • 504 citations

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1991 • 489 citations

Reduction in the Rate of Early Restenosis after Coronary Angioplasty by a Diet Supplemented with n–3 Fatty Acids

1988 • 385 citations

Prognostic significance of progression of coronary atherosclerosis.

1993 • 279 citations

Prevention of restenosis after percutaneous transluminal coronary angioplasty with thromboxane A2-receptor blockade. A randomized, double-blind, placebo-controlled trial. Coronary Artery Restenosis Prevention on Repeated Thromboxane-Antagonism Study (CARPORT).

1991 • 239 citations

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

1987 • 231 citations

Multiple vessel coronary angioplasty: Classification, results, and patterns of restenosis in 494 consecutive patients

1987 • 230 citations

RANDOMISED TRIAL OF FISH OIL FOR PREVENTION OF RESTENOSIS AFTER CORONARY ANGIOPLASTY

1989 • 223 citations

One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry.

1989 • 219 citations

Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty

1987 • 194 citations

Can restenosis after coronary angioplasty be predicted from clinical variables?

1993 • 189 citations

Determinants of restenosis and lack of effect of dietary supplementation with eicosapentaenoic acid on the incidence of coronary artery restenosis after angioplasty

1989 • 167 citations

Prevention of restenosis by lovastatin after successful coronary angioplasty

1991 • 165 citations

Double-blind, randomized, controlled trial of fish oil supplements in prevention of recurrence of stenosis after coronary angioplasty.

1992 • 160 citations

Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty

1989 • 155 citations

Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions

1994 • 125 citations

Effect of lovastatin on intimal hyperplasia after balloon angioplasty: A study in an atherosclerotic hypercholesterolemic rabbit

1991 • 125 citations

Usefulness of fish oil supplements in preventing clinical evidence of restenosis after percutaneous transluminal coronary angioplasty

1989 • 123 citations

Multiple coronary angioplasty: A model to discriminate systemic and procedural factors related to restenosis

1988 • 93 citations

Changes in sequential coronary arteriograms and subsequent coronary events. Surgical Control of the Hyperlipidemias (POSCH) Group

1992 • 89 citations

Changing use of coronary angioplasty and coronary bypass surgery in the treatment of chronic coronary artery disease

1990 • 74 citations

Effect of eicosapentaenoic acid on restenosis rate, clinical course and blood lipids in patients after percutaneous transluminal coronary angioplasty

1990 • 68 citations

Effect of lovastatin on hemorheology in type II hyperlipoproteinemia

1990 • 51 citations

Recurrence of stenoses after coronary angioplasty.

1986 • 21 citations

Background and methods for the lovastatin restenosis trial after percutaneous transluminal coronary angioplasty

1992 • 20 citations

Nitrate therapy: is there an optimal substance and formulation?

1991 • 10 citations

Cited By (0)

Loading...